GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 22 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,832,484 | $13,469,000 | 1.47% |
| Knoll Capital Management, LLC | 206,099 | $1,515,000 | 1.24% |
| 683 Capital Management, LLC | 1,350,000 | $9,923,000 | 0.90% |
| Vivo Capital, LLC | 971,337 | $7,139,000 | 0.67% |
| P.A.W. CAPITAL CORP | 70,000 | $515,000 | 0.56% |
| Ibex Investors LLC | 807,400 | $5,934,000 | 0.48% |
| MEITAV INVESTMENT HOUSE LTD | 639,269 | $4,693,000 | 0.31% |
| Nantahala Capital Management | 879,200 | $6,559,000 | 0.20% |
| Rock Creek Group, LP | 57,201 | $420,000 | 0.19% |
| FIRST MIDWEST BANK TRUST DIVISION | 164,847 | $1,212,000 | 0.17% |